top of page

Known from: 


   PATRICK SCHMITT, Molecular biologist M.Sc.  

  • State-approved pharmaceutical consultant  

  • Certified expert for AM, NEM & Patent valuation

  • Expertise according to § 6 BtMG

  • Qualified responsible person according to § 52 AMG  

  • Medical product consultant according to § 83 MPDG



Professional Experience


since 2021        Project Manager UroQuant  R&D / Regulatory Affairs

                       PolyQuant GmbH


2019-2021       Managing Director  R&D / Regulatory Affairs  

                      Synbionic GmbH

2018-2019       Chief Science Officer  R&D / Regulatory Affairs  

                      Farmako Ltd   

2017-2018       Lecturer Expert Opinions 

                      Johannes Gutenberg University Mainz

since 2014        Freelance expert

                       Sachverständigenkanzlei Patrick Schmitt  


since 2013        Freelance product development & QM consulting  

                       PS Nutraceuticals - Product Development & Consulting



Academic education



since 2019       Doctorate in biology  

                      JGU Mainz  

2015 - 2018     Study of law  

                      JGU Mainz / Saarland University  


2015 - 2019    General Management, M.B.A.

                      Middlesex University London


2015 - 2018     Biology, MSc

                      Johannes Gutenberg University of Mainz


2012- 2015     Molecular Biology, B.Sc.

                     Johannes Gutenberg University of Mainz


2010-2012      Medicine, early study (preclinical)

                     Johannes Gutenberg University of Mainz



since 2014       Certified expert for food supplements  


since 2015       Certified Expert in Patent Valuation


since 2016       State-recognized pharmaceutical consultant


since 2016       Certified expert for pharmaceuticals

since 2018       Wholesale representative § 52 AMG

since 2018       Responsible person for the traffic of narcotics

since 2019       Medical product consultant § 83 MPDG

Selected publications

Patrick Schmitt, Andrea Taboada
Production of Plant-based Active Substances (e.g. Cannabinoids) by Recombinant Microorganisms

Bernhard Lieb, Patrick Schmitt
Randomized double-blind placebo-controlled intervention study on the nutritional efficacy of a food for special medical purposes (FSMP) and a dietary supplement in reducing the symptoms of veisalgia. In: BMJ Nutrition, Prevention & Health. April 30, 2020,
  ISSN  2516-5542 , pp. bmjnph-2019-000042,  doi : 10.1136/bmjnph-2019-000042  

Patrick Schmitt, Bernhard Lieb
Photoprotective oleoresin emulsifier for oral application as a medical device

DE20 2017 006 637 U1

Patrick Schmitt
Dietary supplement in the form of a powder mix for making an electrolyte drink
DE 20 2016 007 986 U1


Germany scholarship for gifted and high-performing students

Federal Ministry of Education and Research / JGU Mainz



Germany scholarship for talented and high-performing students

Federal Ministry of Education and Research / JGU Mainz   


bottom of page